NASDAQ · Biotechnology

KYMR (KYMR) Stock

$119.05 +0.20% NASDAQ: KYMR Healthcare

Valuation

MetricValue
Price$119.05
Market Cap$9.79B
P/E Ratio-36.35
P/B Ratio7.69
P/S Ratio92.57
EPS (TTM)$-3.69
52-Week High$130.05
52-Week Low$39.84
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-21.50%
ROA-18.21%
ROCE-22.30%
Gross Margin-897.44%
Operating Margin-894.87%
Net Margin-285.41%
Debt/Equity0.05
Current Ratio10.49

Annual Financials (USD)

Metric20212022202320242025
Revenue$73.0M$47.0M$79.0M$47.0M$39.0M
Operating Profit$-101.0M$-161.0M$-166.0M$-262.0M$-349.0M
Net Profit$-100.0M$-155.0M$-147.0M$-224.0M$-311.0M
EPS$-2.09$-2.87$-2.52$-2.98$-3.69
Op Margin-138.0%-344.4%-210.6%-555.8%-891.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$606.0M$603.0M$576.0M$978.0M$1.7B
Total Liabilities$146.0M$113.0M$181.0M$142.0M$163.0M
Cash$48.0M$68.0M$110.0M$120.0M$357.0M
Borrowings$18.0M$17.0M$85.0M$88.0M$82.0M

Latest News

Kymera Therapeutics Shares Fall After RBC Downgrade MT Newswires · Jul 13, 2026 American Express, Biogen upgraded: Wall Street's top analyst calls The Fly · Jul 13, 2026 RBC Downgrades Kymera Therapeutics to Sector Perform From Outperform, Lifts Price Target to $115 From $106, Keeps Speculative Risk MT Newswires · Jul 13, 2026 Kymera's CEO Sold $6 Million in Stock After a 170% Run Motley Fool · Jul 12, 2026 Is Kymera (KYMR) the Best Performing American Stock in June 2026? Insider Monkey · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-129.0M$-153.0M$-103.0M$-195.0M$-233.0M
Investing Cash Flow$-101.0M$18.0M$105.0M$-417.0M$-523.0M
Financing Cash Flow$8.0M$4.0M$4.0M$14.0M$0
Net Cash Flow$21.0M$20.0M$41.0M$10.0M$237.0M
Free Cash Flow$-131.0M$-156.0M$-137.0M$-207.0M$-234.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-6.54
EV / EBITDA-33.05
FCF Yield-2.45%
Quick Ratio9.91
Interest Coverage-1659.61
Return 1Y182.99%
Return 3Y506.21%
Return 5Y108.35%

Ownership

Insiders Held2.10%
Institutions Held115.61%
Institutions Float Held118.09%
Institutional HolderSharesReport Date
FMR, LLC11,699,9502026-03-31
Baker Bros. Advisors, LP8,657,2422026-03-31
Avoro Capital Advisors LLC7,474,7472026-03-31
Price (T.Rowe) Associates Inc6,060,8472026-03-31
BVF Inc.5,502,7102026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPGAscentage Pharma Group International $20.18 +4.89% -9.87 $1.88B 0.00%
ACAD $28.89 -0.07% 8.94 $4.95B 0.00%
ACLXArcellx, Inc. $115.07 +0.02% -28.27 $6.73B 0.00%
AKROAkero Therapeutics, Inc. $54.65 +0.00% -19.87 $4.50B 0.00%
CRNX $84.95 +0.00% -16.80 $9.00B 0.00%

About KYMR

KYMR is led by CEO Nello Mainolfi, employs 253 people, headquartered in Watertown, US, publicly traded since 2020.

KYMR stock trades at $119.05 with a market capitalization of $9.79B. The stock is valued at a price-to-earnings (P/E) ratio of -36.35, price-to-book of 7.69, price-to-sales of 92.57. Over the past 52 weeks the stock has ranged between $39.84 and $130.05, and currently trades 8.5% below its 52-week high.

On profitability, KYMR generates a return on equity (ROE) of -21.50%, return on capital employed of -22.30%, an operating margin of -894.87%, a net profit margin of -285.41%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides